Assessing and Treating Pediatric Clients: Mood Disorders

Start with the duration, because it is the most diagnostically loaded fact in the vignette and the easiest to read past. Kara is thirteen and has had temper tantrums, impulsiveness, inappropriate behaviour, poor judgement and sleep problems *for more than eight years* — since she was about five. That is not the trajectory of a depressive episode, which is episodic by definition and would represent a change from her baseline. A symptom set that has been present for two thirds of a child's life is either a chronic condition, a developmental picture, or a response to something enduring in her environment. The brief says so almost explicitly when it asks you to assess whether the symptoms are caused by psychological, social, or underlying growth and development issues, and an answer that reaches straight for an antidepressant has skipped the question it was told to ask first.

So the differential has to be broad before it narrows. The symptom list — irritability, impulsivity, poor judgement, sleep disturbance — is almost perfectly non-specific in a thirteen-year-old, and it maps onto attention-deficit/hyperactivity disorder, oppositional defiant disorder, disruptive mood dysregulation disorder, an anxiety disorder presenting as irritability, an emerging bipolar picture, and the effects of chronic stress, trauma or disrupted attachment. Each of those has different treatment implications and some of them make an antidepressant actively unhelpful. Naming the alternatives you considered and saying what would distinguish them is the single most reliable way to demonstrate assessment rather than assumption, and it costs only a paragraph. The vignette also mentions she was struggling both at home *and* at school, which matters because cross-setting impairment is a diagnostic criterion for several of these. Say what further history you would take as well, because eight years of symptoms means there is a developmental and family history the vignette has not given you that would settle several of these candidates.

Paediatric psychopharmacology is genuinely different from adult prescribing, and the brief flags it twice. Children do not simply need smaller doses. Hepatic metabolism relative to body mass is higher in prepubertal children, which is why some agents need proportionally larger weight-adjusted doses or divided dosing; volume of distribution, protein binding and renal clearance all differ; and puberty changes all of it partway through treatment. On the pharmacodynamic side the developing brain responds differently, which is the accepted explanation for why antidepressant efficacy in paediatric trials is smaller and placebo response larger than in adults. Say which of these applies to the agent you selected and to Kara's age specifically. A paragraph that defines pharmacokinetics and pharmacodynamics without attaching either to a thirteen-year-old girl earns very little. State the weight-based calculation you would actually use rather than gesturing at one, since the marker can check whether the dose you named is consistent with the metabolic argument you just made.

The safety question is not optional here and should not be relegated to the ethics paragraph. Antidepressants carry a boxed warning for increased suicidal ideation and behaviour in children, adolescents and young adults, and only some agents hold paediatric indications at all. That does not mean they should not be used — untreated mood disorder carries its own substantial risk — but it does mean your rationale must show you weighed the two. State the monitoring interval you would use in the first weeks, who is doing the monitoring, and what specifically they are watching for. Prescribing to a minor with a boxed warning and no stated follow-up plan is the failure most likely to cost marks here, precisely because the clinical reasoning otherwise looks complete. Name what you would tell Kara's parents to watch for between appointments too, because most of the monitoring in the first weeks happens at home rather than in your office.

Each decision point asks four questions and only the first is a choice. The rest is argument, and the question about how the result differed from your expectation is where the marks concentrate — it is the only one you cannot answer before you click. Write your prediction down first, so the comparison is genuine rather than reconstructed. The brief tells you outright that some scenarios may have no right decision and that you are expected to learn from each one, which is an unusually direct invitation to write about a choice that did not work. Take it. A submission in which all three decisions succeed exactly as intended reads as one written backwards from the outcome, and it forfeits the reflective content the assignment was designed to elicit. Record what you learned from each decision as the brief asks, since the instruction to demonstrate weighing risks against benefits is a request for visible reasoning rather than for a defensible outcome.

The legal and ethical dimension is distinctive with a minor and deserves its own treatment. Consent is given by a parent while assent comes from Kara, and the two can diverge — a thirteen-year-old may refuse a medication her parents want her to take, or want one they object to. Confidentiality is genuinely limited and she should be told where the limits are before she discloses anything, not after. Add the school's role, since her difficulties are cross-setting and information sharing there needs a basis. Off-label prescribing, if your chosen agent lacks a paediatric indication, carries its own disclosure obligation. Naming these concretely, rather than listing four ethical principles, is what distinguishes an answer about *this* client from an essay about paediatric ethics. Say how you would handle disagreement between Kara and her parents rather than assuming it away, because a plan that depends on the family agreeing has not addressed the situation this presentation most often produces.